STEMI Patient Perceptions Impact Emergency Medical Services Use

This article originally appeared here.
Share this content:
STEMI Patient Perceptions Impact Emergency Medical Services Use
STEMI Patient Perceptions Impact Emergency Medical Services Use

TUESDAY, Dec. 19, 2017 (HealthDay News) -- ST-elevation myocardial infarction (STEMI) patient perceptions, including those involving the speed of transport and concerns about resource misuse, are an important factor in determining emergency medical services (EMS) use, according to a study published online Dec. 13 in the Journal of Evaluation in Clinical Practice.

Matthew Mercuri, Ph.D., from McMaster University in Hamilton, Canada, and colleagues conducted semi-structured interviews with 61 STEMI patients admitted to a large tertiary care center. Patients were classified according to mode of transport to the hospital at the time of the index event (32 EMS, 29 self-transport).

The researchers found that the likelihood of having a Killip Class >1 was higher for EMS users (25 versus 4 percent). Compared with EMS patients, self-transport patients were more likely to perceive EMS as slower (48 versus 0 percent) and express concerns over resources misuse (34 versus 3 percent). The likelihood of acknowledging the benefits of EMS was higher for patients who accessed EMS (44 versus 7 percent); they were also more likely to have been encouraged by a family member to call EMS (34 versus 4 percent).

"STEMI patient perceptions are a key factor in determining EMS use," the authors write. "Health care stakeholders should target the identified barriers to improve utilization of EMS, and develop strategies to optimize care for patients who do not access EMS."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Belimumab Aids Anti-dsDNA, Hypocomplementemic Lupus

Belimumab Aids Anti-dsDNA+, Hypocomplementemic Lupus

More SLE Responder Index responders at week 52 in the belimumab group versus the placebo group

Too Few Adults Taking Epilepsy Meds Have Seizure Control

Too Few Adults Taking Epilepsy Meds Have Seizure ...

Ninety percent of those with active epilepsy take meds; 44 percent of those report seizure control

Pediatric Exposures to Liquid Nicotine Down From 2015 to 2016

Pediatric Exposures to Liquid Nicotine Down From 2015 ...

Still poses serious risk to children; decrease likely in part to law requiring child-resistant packaging

is free, fast, and customized just for you!

Already a member?

Sign In Now »